Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dropping Pills for Coronary Heart Disease (Lipidomics Study)
ChiCTR2400080149Phase 4Completed
- Sponsor
- Yangjiang People's Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Compound Danshen in coronary arteriosclerosis (3 arms), sponsored by Yangjiang People's Hospital. Primary endpoint: Serum lipidomics profile. Started Jan 2024; status: completed.
02
Drugs
Compound Danshen
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2400080149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080149.